Urgency is rising as a wave of winter infections washes over the northern hemisphere. New variants of the disease have been detected in the U.K. and South Africa. The mutations appear to make the virus more contagious and may be increasing infections among healthy young people. In the U.S., more than 2,500 people are dying every day.
China, which has several home-grown vaccines, said on Dec. 19 that it had reached the million-dose milestone. That figures include some people who have already taken the second dose. Russia has vaccinated 440,000 people. Both countries got a head start in August by authorizing domestically produced vaccines before they’d been fully tested.
The U.K. is also making rapid progress delivering the shots and is expected to provide an update on its tally as soon as Wednesday afternoon.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.